Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenue
Product sales	$ 2,065,030	$ 1,550,845
Licensing revenue		609,167
Total revenue	2,065,030	2,160,012
Cost of product sales	1,161,641	1,034,528
Gross profit	903,389	1,125,484
Operating expenses
Research and development	167,287	105,968
Sales and marketing	241,400	202,758
General and administrative	863,743	624,427
Total operating expenses	1,272,430	933,153
Operating income (loss)	(369,041)	192,331
Other income (expenses)
Interest expense	(177,308)	(185,555)
Amortization of deferred financing costs	(13,022)	(13,952)
Total other income (expenses)	(190,330)	(199,507)
Net Loss	$ (559,371)	$ (7,176)
Basic and diluted net loss per common share	$ (0.10)	$ 0.00
Basic and diluted weighted average common shares used to calculate net loss per common share	5,568,802	4,990,971